A critical advance in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently disabled in several forms of tumors, causing uncontrolled body https://tetrabookmarks.com/story21975726/vhh-fragments-revive-tumor-suppressor-p53-a-potential-hope-for-cancer-management